Aspo: Low multiples amid mixed outlook - Evli
This is a third party research report and does not necessarily reflect our views or values
Aspo reports Q2 results on Aug 18. Telko and Leipurin are on a steady track to improve more after last year, while ESL has such low H2 comparison figures that at least some further EBITA recovery should be seen already this year.